Table 4.
Frequency of sarcopenia determined by the Romanian SARC-F, two EWGSOP2 definitions, muscle mass, strength and performance
Men | Women | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sarcopenia | No sarcopenia | Sarcopenia | No sarcopenia | Sarcopenia | No sarcopenia | |||||||
N | % | N | % | N | % | N | % | N | % | N | % | |
Sarcopenia / EWGSOP2 | ||||||||||||
Sarc-F < 4 | 4 | 21.05 | 15 | 78.95 | 3 | 10.34 | 26 | 89.66 | 7 | 14.59 | 41 | 85.42 |
Sarc-F ≥ 4 | 5 | 83.33 | 1 | 16.67 | 8 | 30.77 | 18 | 69.23 | 13 | 40.62 | 19 | 59.38 |
Probable Sarcopenia / EWGSOP2 | ||||||||||||
Sarc-F < 4 | 5 | 26.32 | 14 | 73.68 | 6 | 20.69 | 23 | 79.31 | 11 | 22.92 | 37 | 77.08 |
Sarc-F ≥ 4 | 5 | 83.33 | 1 | 16.67 | 20 | 76.92 | 6 | 23.08 | 25 | 78.12 | 7 | 21.88 |
Muscle mass and strength | ||||||||||||
BIA | 13 | 54.17 | 11 | 45.83 | 13 | 23.64 | 42 | 76.36 | 26 | 32.91 | 53 | 67.09 |
HGS | 9 | 50 | 9 | 50 | 20 | 40.82 | 29 | 59.18 | 29 | 43.28 | 38 | 56.72 |
Muscle performance | ||||||||||||
CS | 3 | 20 | 12 | 80 | 11 | 26.19 | 31 | 73.81 | 14 | 24.56 | 43 | 75.44 |
GS | 6 | 40 | 9 | 60 | 25 | 58.14 | 18 | 41.86 | 31 | 53.45 | 27 | 46.55 |